eases, and a single study even employing 1,880 subjects may lack the statistical power to detect a real association. Accordingly, it will be necessary to verify the association between these three genes and hypertension using a larger number of subjects from the Suita cohort or another population.
Introduction
Essential hypertension is a multifactorial disorder that is influenced by both genetic and environmental factors. Single nucleotide polymorphisms (SNPs) are mostly biallelic, more stable, and more frequent than microsatellite markers, making them suitable for association studies (1) . Over the past few years, many SNPs on candidate genes have been sepathe β1-adrenoreceptor (ADRB1) gene; and the C825T polymorphism in the G-protein β3 subunit (GNB3) gene, a substitution of cytosine (C) for thymine (T) at nucleotide position 825 of GNB3 cDNA. However, there are inconsistencies among the previous association studies (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . In response to these controversial results, we investigated the associations between hypertension and the ADD1/G460W, ADRB1/R389G, and GNB3/C825T polymorphisms using a large cohort representing the general population in Japan (total, n 1,880: 867 males, 1,013 females).
Methods

Subjects
The selection criteria and design of the Suita Study have been previously described (18) (19) (20) . The present study was approved by the Ethics Committee of the National Cardiovascular Center and by the Committee on Genetic Analysis and Genetic Therapy of the National Cardiovascular Center. The genotypes were determined in 1,880 consecutive subjects, who visited the National Cardiovascular Center between April 2002 and February 2003. All subjects provided their written informed consent.
DNA Studies
DNA was isolated from peripheral leukocytes according to standard procedures. Polymorphisms were determined by the TaqMan system. The primers and probes are summarized in Table 1 . The results were analyzed using an ABI PRISM 7700 Sequence Detection System (PE Biosystems, Foster City, USA) using allelic discrimination software supplied by the manufacturer.
Statistical Analysis
Values are expressed as the mean SEM. All statistical analyses were performed with the JMP statistical package (SAS Institute Inc., Cary, USA). Multiple linear regression (blood pressure value) and multiple logistic (presence or absence of hypertension) analyses were performed with other covariates. Subjects were categorized as hypertensive subjects (HTN) when they had a systolic pressure of 140 mmHg or higher and/or a diastolic pressure of 90 mmHg or higher. Subjects who were currently taking hypertensive medication were also categorized as HTN. The effects of polymorphisms on blood pressure and heart rate values were assessed in subjects who were not receiving cardiovascular medications, since HTN with excellent blood pressure control by medication may have normal blood pressure values. We also excluded subjects who were receiving anti-hypertensive treatment, subjects who had had cerebrovascular accidents, subjects with demonstrated ischemic heart disease, and subjects with atrial fibrillation. Differences in numerical data among the groups were calculated by one-way analysis of variance (ANOVA) or the unpaired t-test. The difference in genotype or allelic distribution between normotensive subjects (NT) and HTN, and Hardy-Weinberg equilibrium was analyzed by a χ 2 test. In some settings, the probability ( 
Results
Subjects
The characteristics of the study population are given in Table   32 Hypertens Res Vol. 27, No. 1 (2004) 
ADD1, α-adducin; ADRB1, β1-adrenoceptor; GNB3, G-protein β3 subunit, G, glycine; W, tryptophan; C, cysteine; T, threonine.
2. The observed genotype and allele frequencies in the Suita population were in accordance with Hardy-Weinberg equilibrium (ADD1/G460W, p 0.9897; ADRB1/R389G, p 0.2073; GNB3/C825T, p 0.8307).
ADD1/G460W
The effects of the three polymorphisms on hypertensive status, blood pressure values, and pulse rate are shown in Tables 3-5 . Logistic analysis with age and body mass index (BMI) as covariates indicated that the ADD1/G460W polymorphism (WW 1, WG GG 2) was associated with hypertension only in female subjects ( p 0.0070, pc 0.0420, Table 4 ). The WW genotype of the ADD1/G460W polymorphism was more frequent in HTN. The odds ratio of the WW genotype for hypertension was 1.53 (95% CI, 1.12-2.08) over the WG GG genotype. There were no differences in blood pressure values between NT and HTN (Table 5) . In female subjects, the ADD1/G460W polymorphism tended to be associated with pulse rate ( p 0.0144, pc 0.0864). The neglect of subjects receiving anti-hypertensive medication may have obscured the relationship between the polymorphism and blood pressure values.
ADRB1/R389G
Logistic analysis with age and BMI as covariates indicated that the ADRB1/R389G polymorphism (GG 1, RR RG 2) tended to be associated with hypertension only in male subjects ( p 0.0117, pc 0.0702, Table 4 ). The odds ratio of the GG genotype for hypertension was 0.38 (95% CI, 0.17-0.78) over the RR RG genotype. Alcohol consumption is a well-known determinant of blood pressure level, especially in male subjects. The ADRB1/R389G polymorphism (GG 1, RR RG 2) tended to be associated with hypertensive status when also adjusted for alcohol consumption ( p 0.0109, pc 0.0654, odds ratio 0.37 [95% CI, 0.16-0.48]). There were no differences in blood pressure values between NT and HTN (Table 5) . Again, the neglect of subjects receiving anti-hypertensive medication may have obscured the relationship between the polymorphism and blood pressure values.
GNB3/C825T
We did not find any association between the GNB3/C825T polymorphism and hypertensive status, systolic blood pressure, or diastolic blood pressure in all subjects, male subjects, or female subjects (Tables 3-5) .
Discussion
In the present study, we investigated the associations between hypertension and three polymorphisms, ADD1/ G460W, ADRB1/R389G, and GNB3/C825T, in a population-based sample (the Suita Study) consisting of 1,880 subjects. Our results indicate that the WW genotype of the ADD1 gene may be involved in hypertension in female subjects.
The ADD1 gene in humans is highly homologous to that in rats. Known point mutations, one each in the α-and β-adducin subunits, account for up to 50% of the difference in blood pressure between the Milan hypertensive and normotensive rat strains (21) . Based on initial case-control and linkage analyses, the ADD1/G460W polymorphism was implicated in the genetic component of hypertension in Italian and French populations (3). In addition, a group of Italian hypertensive subjects with the W allele had lower plasma renin levels and showed a significantly greater fall in blood pressure with sodium restriction or diuretic treatment (3). On the other hand, this association was not confirmed by two different studies in Scottish populations (6, 8) . In the Japanese population, while Tamaki et al. reported that the ADD1/ G460W polymorphism was involved in hypertension (5), Kato et al. did not support this association (7). Sugimoto et al. demonstrated that this polymorphism is associated with low renin hypertension in younger subjects (22) . The present study indicated that the ADD1/G460W polymorphism was influential in female subjects, but the corrected p value ( pc 0.045) was marginal. Accordingly, additional independent replications in the Japanese population are required to confirm the present association.
In the present study, the ADD1/G460W polymorphism was associated with hypertension only in female subjects, but not in male subjects. It remains to be clarified why these polymorphisms do not equally contribute to hypertension in both sexes. Recently, low renin hypertension has been reported to be a significant predictor of systolic sodium sensitivity in females only (23). Izawa et al. also demonstrated a gender difference in genetic polymorphisms and hypertension (15) . Accordingly, these results may suggest that sexbased differences should be considered in the association between genetic polymorphisms and hypertension.
Two common polymorphisms, S49G and R389G, were identified in the ADRB1 gene (24) . The R389G polymor- 
Odds ratio with its 95% confidential interval is shown. Logistic analysis with age and BMI as covariates was performed. P values were corrected ( pc) by multiplying 6 ([3 SNPs] [2 genders], Bonferroni). ADD1, α-addcin; ADRB1, β1-adrenoceptor; GNB3, G-protein β3 subunit; R, arginine; G, glycine; C, cysteine; T, threonine; BMI, body mass index. PR, pulse rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; Res. SBP and Res. DBP, residuals of SBP and DBP for age and body mass index, respectively. We excluded subjects who were receiving anti-hypertensive or cardiovascular medication, subjects who had had a cerebrovascular accident, subjects with demonstrated ischemic heart diseases, and subjects with atrial fibrillation. P was calculated by ANOVA. P values were corrected ( pc) by multiplying 6 [(3 SNPs) (2 genders), Bonferroni].
phism is located in the intracellular cytoplasmic tail near the seventh transmembrane region of the receptor, which is the putative Gs-protein binding domain. The R389 variant mediates a higher level of isoproterenol-stimulated adenylate cyclase activity than the G389 variant in vitro (25) . In accordance with this in vitro study, Bengtsson et al. reported that homozygotes for the ADRB1/R389 allele had an increased risk of developing hypertension in a case-control study (9) . Their genotype-discordant sibling pair analysis demonstrated that siblings who were homozygotes for the R389 allele had significantly higher diastolic pressures and higher heart rates than siblings carrying one or two copies of the G389 allele. However, McCaffery et al. reported that subjects carrying any ADRB1/G389 allele, but not the ADRB1/R389 allele, exhibited elevated systolic and diastolic blood pressure (10). The present study, which employed a dominant model, indicated that the GG genotype of the ADRB1 gene tended to be associated with hypertension in male subjects. However, the frequency of the GG genotype was relatively low, and the sample power was weak (sample power: 0.69, α 0.05, twotailed). A much larger number of subjects may be required to confirm the present association. The GNB3/C825T polymorphism is associated with the occurrence of a splicing variant, GNB3-s (encoding Gβ3-s), in which nucleotides 498-620 of exon 9 are deleted. This inframe deletion causes the loss of 41 amino acids and one WD repeat domain of the Gβ subunit (11) . A significantly higher frequency of the GNB3/T825 allele has been reported in subjects with essential hypertension using unselected normotensive control subjects of European origin in three independent studies (11-13), but not in a fourth study (14) . In blacks, the GNB3/T825 allele was reported to be a susceptibility factor for the development of hypertension (17) . In a Japanese population, Izawa et al. demonstrated an association between hypertension and the GNB3/C825T polymorphism in male subjects (15) . However, Ishikawa et al. reported that the GNB3/C825T polymorphism was associated with serum potassium and total cholesterol levels, but not with blood pressure (16) . The present study revealed that the GNB3/T825 allele is not associated with either hypertensive status (15, 16) or the total cholesterol level (all subjects, p 0.9381), contrary to previous reports (15, 16) .
As stated above, the present results do not agree with those in previous reports. Almost all common variants may have only a modest effect on common diseases, and a single study may lack the statistical power to detect a real association (26, 27) . Recently, it was reported that a meta-analysis of genetic association studies may support the notion that common variants may contribute to a susceptibility to a multifactorial common disease (27) . It is recommended that a single, nominally significant association should be viewed as tentative until it has been independently replicated at least once, and preferably twice (27) . Accordingly, it will be necessary to verify the association between these three genes and hypertension using a larger number of subjects from the Suita cohort or another population.
In conclusion, the present tentative results suggest that the WW genotype of the ADD1 gene may be involved in hypertension in female subjects. The GG genotype of the ADRB1 gene may play a protective role against hypertension in male subjects.
